Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Published Online: 2022-09-12
Journal: Nature MedicineLoading...
Authors: Alan Nicholas•Ann Johnson•Bruce E. Johnson•Chris Rivard•Ciaran J. McNamee•David J. Finley•David J. Kwiatkowski•David P. Carbone•David R. Camidge•David S. Shames•Dwight H. Owen•Edward B. Garon•Elaine Shum•Eric B. Haura•Eric Toloza•Filiz Oezkan•G. Alexander Patterson•Gerard Lozanski•Ignacio I. Wistuba•Jamie E. Chaft•Jay M. Lee•Jennifer W. Carlisle•Jessica Grindheim•Justin D. Blasberg•Katja Schulze•Maciej Pietrzak•Marianna Koczywas•Mark G. Kris•Michal Seweryn•Misako Nagasaka•Paul A. Bunn•Saiama N. Waqar•Saiama N. Waqar•Stephanie Hilz•Valerie W. Rusch•Woo Yul Byun•Yan Tang
